The Nexus of Innovation: A Comprehensive Analysis of Internal Revenue Code § 41 and the Massachusetts Research and Development Tax Credit

Internal Revenue Code § 41 provides a federal tax credit for increasing research activities, serving as the foundational definition for what constitutes qualified innovation in the United States. The Massachusetts Research and Development tax credit, codified under M.G.L. c. 63, § 38M, adopts these federal standards while imposing a strict requirement that the research activities must be physically conducted within the Commonwealth to stimulate local economic growth.1

This legal and regulatory intersection creates a dual-layered incentive system designed to lower the cost of technical experimentation for businesses. While the federal credit rewards innovation regardless of domestic location, the Massachusetts credit functions as a specialized industrial policy tool, specifically targeting sectors like life sciences, advanced manufacturing, and climatetech.1 Understanding the interaction between these two codes requires a deep dive into the four-part test of qualified research, the nuances of state-level sourcing, and the administrative guidance issued by the Massachusetts Department of Revenue (DOR) through its various Technical Information Releases (TIRs) and regulations.5

The Federal Framework: Internal Revenue Code § 41

Internal Revenue Code § 41 is the primary vehicle for federal R&D incentives. It defines the parameters for “Qualified Research Expenses” (QREs) and establishes the criteria for what activities qualify as research.8 The federal statute is intentionally broad to encompass various industries but rigorous in its evidentiary requirements to prevent abuse.

The Four-Part Test of Qualified Research

To qualify for the credit under IRC § 41(d), a research activity must satisfy a cumulative four-part test. Failure to meet any single part disqualifies the entire activity from being considered “qualified research”.9

The “Permitted Purpose” test ensures that the research is intended to improve a “business component,” which is defined as any product, process, computer software, technique, formula, or invention held for sale, lease, or license, or used in the taxpayer’s trade or business.9 It is important to note that research related to style, taste, cosmetic, or seasonal design factors is explicitly excluded.10

The “Elimination of Uncertainty” and “Process of Experimentation” tests are intrinsically linked. Uncertainty exists if the information available to the taxpayer does not establish the capability or method for developing or improving the business component, or the appropriate design of the business component.10 The process of experimentation must be designed to evaluate one or more alternatives to achieve a result where the capability, method, or design is uncertain as of the beginning of the research activities.10

Categorization of Qualified Research Expenses (QREs)

Under IRC § 41(b), QREs are divided into in-house research expenses and contract research expenses.8 In-house expenses include wages paid to employees, supplies used in the conduct of research, and certain computer rental costs (now primarily interpreted as cloud computing costs).8

Contract research is subject to specific constraints: the taxpayer must retain substantial rights to the research results and must bear the economic risk of the research.9 If the third party is guaranteed payment regardless of the outcome, the expenses may be deemed “funded research” and thus excluded under IRC § 41(d)(4)(H).8

The Massachusetts Adoption: M.G.L. c. 63, § 38M

Massachusetts enacted its research credit to complement the federal incentive, but with a strategic focus on local investment. The state statute, M.G.L. c. 63, § 38M, adopts the federal definitions of QREs and qualified research, but it adds a critical geographic overlay.1

Statutory Alignment and IRC Conformity Dates

The Massachusetts research credit is “statically” conformed to the Internal Revenue Code. For the purposes of calculating the credit under the “Traditional Method,” the state follows IRC § 41 as it was in effect on August 12, 1991.5 For the “Alternative Simplified Method” (ASM), the state follows the IRC as of January 1, 2014.5

This dual-conformity creates a complex compliance environment. For example, recent federal changes to IRC § 174 requiring the capitalization and amortization of R&D expenses do not automatically alter the Massachusetts § 38M credit calculation, although they may affect the state’s corporate excise base through the definition of net income.9

The “Conducted In” Requirement

The most significant departure from federal law is the requirement that research must be conducted in Massachusetts to qualify for the state credit.5 This requirement applies to every category of QRE:

• Wages: Only wages for services performed within the physical boundaries of Massachusetts are eligible. If an employee works in multiple states, their wages must be prorated based on the ratio of days worked in Massachusetts to total workdays.5
• Supplies: Supplies must be used or consumed at a research facility located in Massachusetts.5
• Computer Fees: Payments for the use of computers (such as cloud servers) are only eligible if the computers are located in Massachusetts and the research using them is also conducted in the state.5
• Contract Research: $65\%$ of payments to contractors are eligible only to the extent the contractor performs the research at a facility in Massachusetts.5

Remote Work and Multi-State Proration

The rise of remote work has introduced significant complexity to the “conducted in” requirement. DOR Directive 02-15 and subsequent guidance (including pandemic-era regulations like 830 CMR 62.5A.3) clarify that the location of the individual performing the service—not the location of the employer’s headquarters—determines the eligibility of wages.20

For instance, if a biotechnology firm is headquartered in Cambridge but employs a research scientist who works from a home office in New Hampshire, those wages are generally ineligible for the Massachusetts § 38M credit, even if the research benefits a Massachusetts business component.20 Conversely, if a scientist lives in New Hampshire but commutes to a lab in Worcester, their wages qualify for the days they are physically present in the Worcester lab.18

Calculation Methodologies: Traditional vs. Alternative Simplified

Since the tax years beginning on or after January 1, 2015, Massachusetts corporations have had the option to choose between two primary calculation methods for their research credit.16

The Traditional Method (Option 1)

The Traditional Method provides a credit equal to the sum of $10\%$ of “incremental” QREs plus 15% of “basic research” payments.5 The incremental portion is calculated as the excess of current-year Massachusetts QREs over a “base amount”.5

The Massachusetts base amount calculation differs from the pre-2015 federal method. It is calculated by multiplying a “fixed-base ratio” by the average annual gross receipts of the taxpayer for the four taxable years preceding the credit year.6 The fixed-base ratio is determined by taking the total QREs for the third and fourth taxable years preceding the credit year and dividing that sum by the total gross receipts for those same two years.6 This ratio is capped at $16\%$.6

The Alternative Simplified Method (ASM) (Option 2)

Modeled after the federal Alternative Simplified Credit (ASC), the Massachusetts ASM was introduced to simplify the credit for companies that did not have the historical data required for the traditional method or for those whose research spending was flat or declining.24

The ASM credit is calculated as a percentage of the amount by which current-year Massachusetts QREs exceed $50\%$ of the average QREs for the three preceding taxable years.5 If the taxpayer had no QREs in any of the three preceding years, the credit is $5\%$ of the current year’s QREs.6

The election to use the ASM is generally made on the original tax return and must be applied by all members of an aggregated group.7 However, recent guidance in TIR 25-3 has relaxed this for certain taxpayers following the State Street decision.32

Administrative Guidance: DOR Regulations and TIRs

The Massachusetts DOR provides detailed guidance on the implementation of $\S 38M$ through its regulatory code and Technical Information Releases. These documents serve as the “manual” for taxpayers and auditors alike.

Regulation 830 CMR 63.38M.1 and 63.38M.2

Regulation 63.38M.1 provides the foundational rules for the pre-2015 credit, while the proposed (and widely followed) 63.38M.2 outlines the rules for the post-2015 era, including the ASM and the new fixed-base ratio rules.5

These regulations specify:

• Accounting Rules: Corporations must use the same method of accounting for the state credit as they use for the federal credit.5
• Aggregated Groups: Controlled groups of corporations must compute a single group credit and then allocate it among the members based on each member’s share of the total QREs.5
• Mergers and Acquisitions: In a merger, the surviving corporation generally retains its own credit carryovers, but the carryovers of the acquired corporation may be lost or subject to severe limitation unless specific continuity of business requirements are met.5

TIR 14-13 and TIR 14-16: The 2014 Reform

These two TIRs were issued to explain the massive changes enacted by the 2014 Economic Development Act. They introduced the ASM, established the phase-in rates, and corrected technical errors in the initial legislation regarding how the $50\%$ threshold was applied to the $7.5\%$ rate.16 These documents are essential for understanding the transition from the old “fixed-base percentage” (which relied on 1980s data) to the modern “fixed-base ratio” (which uses a rolling period).24

TIR 25-3: The Financial Institution Breakthrough

One of the most significant recent developments in Massachusetts tax law is TIR 25-3, issued in response to the State Street Corporation v. Commissioner of Revenue (2024) decision by the Appellate Tax Board.32

Historically, the DOR had maintained that the § 38M research credit was only available to “business corporations” subject to tax under M.G.L. c. 63, § 39, effectively excluding banks and financial institutions taxed under § 2.32 The Board ruled, and the DOR subsequently conceded in TIR 25-3, that financial institutions are eligible for the research credit.1 This opens the door for significant claims in the fintech and banking sectors, allowing these entities to file amended returns or abatement applications to claim credits for open tax years.33

Specialized Innovation Credits: Life Sciences and Beyond

Massachusetts has tailored its R&D incentives to support specific high-growth industries, often providing benefits that go beyond the standard non-refundable § 38M credit.

The Massachusetts Life Sciences Center (MLSC) Program

The MLSC administers a specialized tax incentive program that allows certified life sciences companies to access unique R&D benefits.35

• Refundability: Certified companies may elect to receive a refund of up to $90\%$ of their unused § 38M research credits.35 This is a massive benefit for pre-revenue biotech firms that have no tax liability to offset but need cash flow for ongoing trials.
• FDA User Fees Credit: Companies can claim a $100\%$ credit for user fees paid to the FDA for drug or device approvals, provided the research was conducted primarily in Massachusetts.35
• Life Sciences Research Credit ($\S 38W$): This separate credit targets clinical trial expenses that might not qualify under the strict “technological in nature” requirements of § 38M but are essential for life sciences commercialization.25

Defense-Related Activities

M.G.L. c. 63, § 38M(i) allows corporations to calculate their research credit separately for “defense-related activities”.6 This is particularly relevant for the Commonwealth’s robust aerospace and defense sector.

Defense-related activities are defined as research and development pursuant to a contract or subcontract for the production of arms, ammunition, or implements of war for military purposes.7 The 2024 Schedule RC instructions clarify that this now includes research into medical supplies for treating threats related to chemical, biological, or nuclear agents.6 This separate calculation allows defense contractors to isolate their high-growth military research from their potentially flatter commercial research, optimizing the total credit yield.6

The Climatetech Incentive

As part of the 2024 “Act Relative to Strengthening Massachusetts’ Economic Leadership,” the Commonwealth introduced a new climatetech incentive program.4 Certified climatetech companies can receive a research credit awarded at the discretion of the MassCETC.4 This credit mirrors the § 38M structure ($10\%$ of excess QREs) but is part of a broader package aimed at stimulating innovation in clean energy and emissions reduction.4

Limitations and Practical Application

Even if a corporation generates a significant research credit, several statutory caps limit the amount that can be used to reduce tax liability in any given year.

The $25,000 + 75% Rule

The Massachusetts research credit is limited to $100\%$ of the first $\$25,000$ of corporate excise due, plus $75\%$ of any excise due in excess of $\$25,000$.1 Furthermore, the credit cannot reduce the excise below the statutory minimum of $\$456$.1

For combined groups, the $\$25,000$ threshold is shared among all members.1 However, a member with excess credits can share those credits with other group members to the extent those members have remaining capacity under their own $75\%$ caps.5

Carryforward Mechanisms

Massachusetts provides two distinct ways to handle unused credits:

1. 15-Year Carryforward: Credits that are not used because they exceed the total excise due for the year can be carried over for 15 taxable years.2
2. Indefinite Carryforward: Credits that are disallowed solely because of the $75\%$ limitation (i.e., the credit was available, but the cap prevented its use) can be carried forward indefinitely.1

This distinction is crucial for long-term tax planning. Companies with massive R&D investments but low tax liabilities (like scaling tech firms) must carefully track which credits fall into which carryforward bucket to ensure no credits expire prematurely.1

Case Study: Implementing the Massachusetts R&D Credit

To illustrate the interplay between IRC § 41 and M.G.L. c. 63, § 38M, consider a mid-sized medical device manufacturer, “BayState MedTech,” with operations in Massachusetts and Rhode Island.

Step 1: Identifying Federal QREs

BayState MedTech conducts research into a new robotic surgical arm. Under IRC § 41, they identify the following costs:

• Wages: $\$2,000,000$ for engineers (direct conduct and supervision).
• Supplies: $\$500,000$ for prototype materials.
• Contract Research: $\$1,000,000$ paid to a software firm to develop the arm’s control algorithms.

Total Federal QREs = $\$2,000,000 + \$500,000 + (0.65 \times \$1,000,000) = \$3,150,000$.

Step 2: Applying the Massachusetts “Conducted In” Filter

The company must now isolate the Massachusetts portion of these expenses:

• Wages: Of the $\$2,000,000$ in wages, $\$1,500,000$ was paid to engineers working in the Waltham, MA lab. The remaining $\$500,000$ was paid to engineers in Providence, RI. Only the $\$1,500,000$ qualifies for the MA credit.5
• Supplies: All $\$500,000$ in materials were used in the Waltham lab.
• Contract Research: The software firm is located in Boston. Since the work was performed in Massachusetts, the full $65\%$ of the contract ( $\$650,000$) qualifies.5

Total Massachusetts QREs = $\$1,500,000 + \$500,000 + \$650,000 = \$2,650,000$.

Step 3: Choosing a Calculation Method

BayState MedTech has seen steady growth in research. They evaluate both the Traditional and ASM methods.

Option A: ASM Calculation (Assuming 2024 Tax Year)

• Current MA QREs: $\$2,650,000$.
• 3-Year Average MA QREs: $\$2,000,000$.
• ASM Base ($50\%$ of average): $\$1,000,000$.
• Credit Amount: $10\% \times (\$2,650,000 – \$1,000,000) = \$165,000$.23

Option B: Traditional Method

• Current MA QREs: $\$2,650,000$.
• Fixed-Base Ratio (from years $-3$ and $-4$): $5\%$.
• 4-Year Average Gross Receipts: $\$30,000,000$.
• Base Amount: $0.05 \times \$30,000,000 = \$1,500,000$.
• Credit Amount: $10\% \times (\$2,650,000 – \$1,500,000) = \$115,000$.6

BayState MedTech elects the ASM to maximize their benefit at $\$165,000$.

Step 4: Applying Excise Limitations

BayState’s Massachusetts corporate excise before credits is $\$200,000$.

• First $\$25,000$: Eligible for $100\%$ offset ($\$25,000$).
• Excess Excise ($200k – 25k$): $\$175,000$.
• $75\%$ Cap on Excess: $0.75 \times \$175,000 = \$131,250$.
• Total Maximum Credit Use: $\$25,000 + \$131,250 = \$156,250$.

The company uses $\$156,250$ of its $\$165,000$ credit. The remaining $\$8,750$ is carried forward indefinitely because it was disallowed by the $75\%$ rule.1

Economic Landscape and Statistical Context

The Massachusetts research credit is a massive driver of the state’s “Innovation Economy.” This sector accounts for nearly $40\%$ of all jobs in the Commonwealth and continues to attract record levels of capital investment.3

The presence of organizations like Mass General Brigham, which receives nearly one-third of all NIH funding coming into the Commonwealth, underscores the scale of research being conducted.44 This activity ripples through the economy, with Mass General Brigham alone responsible for an estimated 625,000 jobs through direct and multiplier effects.44

However, the state faces challenges. The high cost of living and the prevalence of remote work present threats to the geographic concentration of talent.3 The strict “conducted in” requirement of the § 38M credit acts as a counter-balance, incentivizing firms to maintain physical footprints in Massachusetts even as remote work trends pull employees across state lines.3

Compliance and Documentation Standards

Given the complexity of the credit, the DOR and the IRS maintain high standards for documentation. Under IRC § 41, the burden of proof is on the taxpayer to substantiate every dollar of QREs.9

Recordkeeping Requirements

Taxpayers must maintain records that identify the specific business components to which the research relates.10 This often requires:

• Time Tracking: Contemporaneous records (e.g., project logs, timesheets) showing the hours spent by each employee on qualified vs. non-qualified activities.
• Project Documentation: Technical reports, design blueprints, test results, and meeting minutes that prove the “process of experimentation” occurred.9
• Financial Records: General ledgers and invoices that tie supply costs and contractor payments directly to research projects.

The Massachusetts DOR recommends retaining these records for at least three to seven years, as the state may examine multiple prior years to verify base period calculations.1

Proposed Changes to Form 6765

At the federal level, the IRS has proposed significant updates to Form 6765, which is used to claim the research credit. The new form will likely require detailed project-by-project breakdowns of QREs, increasing the administrative burden on taxpayers but providing the IRS with more granular data for audits.13 Since the Massachusetts Schedule RC adopts many federal definitions, these changes are expected to influence state-level reporting expectations as well.

Strategic Integration for Business Growth

For a business operating in Massachusetts, the § 38M credit is more than just a tax line item; it is a strategic asset.

1. Modeling Both Methods: Companies should model their credit under both the Traditional and ASM methods every year. Fluctuations in gross receipts or a pivot in research intensity can make one method significantly more advantageous than the other.24
2. Sourcing Strategy: When hiring new engineers or scientists, the tax implications of their work location should be considered. A remote employee in another state may cost the company an effective $10\%$ more than a Massachusetts-based employee due to the loss of the state R&D credit.18
3. Life Sciences Certification: Any company even remotely involved in medical technology, pharmaceuticals, or bioinformatics should seek MLSC certification to unlock the potential for refundable credits.35
4. Audit Readiness: Implementing a robust R&D tracking system before claiming the credit is essential. Retrospective “studies” are more prone to audit adjustment than contemporaneous tracking systems.1

Future Outlook

The Massachusetts innovation landscape is currently in a state of rapid evolution. The 2024 Economic Development Act and the subsequent 2025 budget updates signal a continued commitment to using tax policy to drive social and economic goals.4 The expansion of the credit to include climatetech and the landmark inclusion of financial institutions via the State Street decision suggest that the definition of “innovation” in the Commonwealth is broadening.4

As the global economy becomes increasingly digitised and decentralized, the tension between the state’s geographic requirements and the reality of remote work will likely become a primary focus of future legislation and litigation. For now, the integration of IRC § 41 and M.G.L. c. 63, § 38M remains the most powerful tool in the Massachusetts tax code for rewarding the technical experimentation that fuels the Commonwealth’s prosperity.

Conclusion

The Massachusetts Research and Development tax credit represents a sophisticated synthesis of federal technical standards and state-specific economic objectives. By anchoring its definitions in IRC § 41, the Commonwealth ensures a high degree of technical rigor, while its “conducted in” requirement ensures that the fiscal benefits of innovation are shared by the local workforce and infrastructure. Whether through the non-refundable § 38M credit for traditional manufacturers or the refundable incentives for life sciences pioneers, Massachusetts has established a world-class framework for de-risking the future of industry. For professional tax practitioners and business leaders, mastering the nuances of these codes—from fixed-base ratios to multi-state proration—is essential for maximizing the value of every dollar invested in innovation.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/